Interactive Discussions are informal, moderated discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic. Each discussion will be led by a facilitator who keeps the discussion on track and the group engaged. For this in-person event, the facilitator will lead from the front of the room while attendees remain seated to promote social distancing. To get the most out of this format, please come prepared to share examples from your work, be a part of a collective, problem-solving session, and participate in active idea sharing.


9:45 am Interactive Discussions


Genomics and Molecular Phenotyping for Precision Health
Moderator: Erica F. Sanford Kobayashi, MD, Assistant Professor, Rady Children's Hospital San Diego

Elevating the Value of At-Home Testing: What Can We Do Now?
Moderator: Hoi-Ying Elsie Yu, PhD, System and Core Laboratory Director, Chemistry, Toxicology and Point-of-Care Testing, Geisinger Health System

Advances in Liquid Biopsy for Early Detection and Screening
Moderator: Minetta C. Liu, MD, Professor & Research Chair, Oncology & Consultant, Lab Medicine & Pathology, Mayo Clinic & Foundation

Assay Development and Technology Advances for Spatial Multi-Omic Analysis
Moderator: Daniel T. Chiu, PhD, A. Bruce Montgomery Professor of Chemistry; Endowed Professor in Analytical Chemistry; Professor of Bioengineering, University of Washington


3:35 pm Interactive Discussions


The Changing Landscape of Diagnostics Reimbursement and Market Access in the Post-Pandemic Era
Moderator: Lon Castle, MD, CMO, Molecular Genetics & Personalized Medicine, eviCore healthcare

Innovation and Future Directions in Infectious Disease Diagnostics: COVID-19 and Beyond
Moderator: Christopher W. Woods, MD, MPH, Professor, Medicine, Global Health & Pathology, Duke University

Biomarker-Enabled Precision Medicine: Status Update and Future Opportunities
Sam Hanash, MD, PhD, Director, Red & Charline McCombs Institute; Evelyn & Sol Rubenstein Distinguished Chair, Cancer Prevention; Professor, Clinical Cancer Prevention-Research, Translational Molecular Pathology, University of Texas MD Anderson Cancer Center


Register Now
March 26-27, 2024

AI in Precision Medicine

Implementing Precision Medicine

At-Home & Point-of-Care Diagnostics

Liquid Biopsy

Spatial Biology

March 27-28, 2024

AI in Diagnostics

Diagnostics Market Access

Infectious Disease Diagnostics

Multi-Cancer Early Detection

Single-Cell Multiomics